| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | EP0752884B1 Method of treating auto-immune diseases using type one interferons |
| 07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
| 07/28/2004 | CN1516705A Novel aryl fructose-1,6-bisphosphatase inhibitors |
| 07/28/2004 | CN1516701A (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516696A Halogen compounds having thrombopoietin receptor agonism |
| 07/28/2004 | CN1516691A Phenylpyridine carbonyl piperazine derivative |
| 07/28/2004 | CN1516690A Heterocyclic derivatives and medicines |
| 07/28/2004 | CN1516689A Process for production of piperidine derivative fexofenadine |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516606A Dry powder inhalation system for transpulmonary administration |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516596A Method of modulating activity of calcium channels in cardiac cells and reagents therefor |
| 07/28/2004 | CN1516587A Quinazoline derivatives capable of promoting release of parathyroid |
| 07/28/2004 | CN1516585A Process for preparing paroxetine HCI which limits formation of pink colored compounds |
| 07/28/2004 | CN1516581A Amino-sulfonyl-containing active compound (COX-2 inhibitors), polyethylene glycol and removing free radical antioxidate and liquid |
| 07/28/2004 | CN1516580A Sulfonamides |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515591A Growth hormone and serum albumni recombinant fusion protein |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515567A New benzothiaheptylyin with ileal bile acid transfer and taurocholate absorption inhibitor activity |
| 07/28/2004 | CN1515566A Substituted chromene derivative for curing inflammation |
| 07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
| 07/28/2004 | CN1515554A Intermediate compound for producing 2-amino-6-(2-substituted-4-phenoxy) substituted pyridine compound |
| 07/28/2004 | CN1515551A 1,2-indane or indoline derivative |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1515317A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515316A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515312A Shenitong (enteric solubility capsule) and its preparation method |
| 07/28/2004 | CN1515267A Health plaster with the functions of promoting blood circulation and discharging toxicity |
| 07/28/2004 | CN1515261A Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 07/28/2004 | CN1515258A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515254A Combined therapeutic method for osteoporosis |
| 07/28/2004 | CN1515253A New application of 1,3-propylene glycol derivative |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159341C Method of treatment of corticosteroid induced osteopenia |
| 07/28/2004 | CN1159340C Martentoxin as one great-conductance calcium-activating potassium channel blocker and its prepn and use |
| 07/28/2004 | CN1159337C Steroides sulfatase inhibitors and methos for making and using same |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159305C Novel 2-(N-cyanoimino) thiazolidin-4-one derivatives |
| 07/28/2004 | CN1159299C Arylakylpyridzinones |
| 07/28/2004 | CN1159295C Inhibitors of metalloproteinases |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/28/2004 | CN1159039C Capsule, oral liquid and face mask with health care function |
| 07/28/2004 | CN1159030C Capsule for curing varicosis and its preparing method |
| 07/28/2004 | CN1159025C Chinese medicine for optimally taking care of brain health |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159012C Pharmaceutical composition of combination of piperidinoalkanol-decongestant |
| 07/28/2004 | CN1159008C Concentrated granular medicine for treating baby cold and preparation preocess thereof |
| 07/28/2004 | CN1159007C Benzimidazole compounds |
| 07/27/2004 | US6768026 Hormone inhibitors comprising carbocyclic ketones such as 3-(5-methoxyheptyl)-2-cyclohexenone used for prophylaxis of acne, alopecia, keloids or osteoarthritis |
| 07/27/2004 | US6768019 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1h-naphthalene-2 -one oxime |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
| 07/27/2004 | US6767912 Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767907 For therapy of psychic and neurologic disorders |
| 07/27/2004 | US6767894 Use of ciliary neurotrophic factor |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/27/2004 | CA2251197C The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders |
| 07/27/2004 | CA2118512C Agents for treating substance abuse disorders |
| 07/22/2004 | WO2004061115A1 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF |
| 07/22/2004 | WO2004061107A1 Cell growth inhibitor using sphingosine kinase 2, method of constructing fused protein having its nuclear localization signal, method of screening drug candidate, and screening kit |
| 07/22/2004 | WO2004061101A1 Method of selecting novel immunosuppressant |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004060892A1 Fused n-containing heterocyclic compounds and medicinal use thereof |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060404A1 Drug carrier |
| 07/22/2004 | WO2004060400A1 Antipsychotic molecular-targeting epithelial growth factor receptor |
| 07/22/2004 | WO2004060399A1 Body weight gain inhibitor |
| 07/22/2004 | WO2004060395A1 Agent for improving life expectancy in therapy of malignant tumor |
| 07/22/2004 | WO2004060385A1 Ophthalmic therapeutic composition |
| 07/22/2004 | WO2004060373A1 Therapeutic agent for wet age-related macular degeneration |
| 07/22/2004 | WO2004060055A1 Wt1 transgenic animal |
| 07/22/2004 | WO2004037187A8 Metal-containing materials, compositions and methods |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | WO2004006835A3 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 07/22/2004 | WO2003087304A3 Tri-substituted heteroaryls and methods of making and using the same |
| 07/22/2004 | WO2003087086A3 Substituted indoles |
| 07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/22/2004 | WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |